Notice2022-04926

Importer of Controlled Substances Application: Peace of Mind Pharmaceuticals LLC

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 9, 2022

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Peace of Mind Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 46 (Wednesday, March 9, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 46 (Wednesday, March 9, 2022)]
[Notices]
[Pages 13313-13314]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04926]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-980]


Importer of Controlled Substances Application: Peace of Mind 
Pharmaceuticals LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Peace of Mind Pharmaceuticals LLC has applied to be registered 
as an importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 8, 2022. Such persons may also file a written request for a 
hearing on the application on or before April 8, 2022.

ADDRESSES: DEA requires that all comments be submitted electronically 
through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the webpage or 
attach a file for lengthier comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the online instructions at that site for 
submitting comments. Upon submission of your comment, you will receive 
a Comment Tracking Number. Please be aware that submitted comments are 
not instantaneously available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment. All requests for a hearing must be sent to: 
(1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 
Morrissette Drive, Springfield, Virginia 22152; and (2) Drug 
Enforcement Administration, Attn: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests 
for a hearing should also be sent to: Drug Enforcement Administration, 
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 
22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on March 15, 2021, Peace of Mind Pharmaceuticals LLC, 
3003 East 3rd Avenue, Suite B-109A, Denver, Colorado 80206-5110, 
applied to be registered as an importer of the

[[Page 13314]]

following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Pentobarbital..........................    2270  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance as bulk 
active pharmaceutical ingredient (API) for distribution to compounding 
pharmacies. It is intended for pharmacies who seek to compound the 
material into dosage units that will be distributed to terminally ill 
patients for ``medical aid in dying'' (MAID) in U.S. states where MAID 
is authorized. No other activity for this drug code is authorized for 
this registration.
    Approval of permit applications can occur only when a registrant's 
business activity is consistent with what is authorized under 21 U.S.C. 
952(a)(2). Authorization will not extend to the import of Food and Drug 
Administration-approved or non-approved finished dosage forms for 
commercial sale.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04926 Filed 3-8-22; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>
Indexed from Federal Register on March 9, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.